Table 2 Prevalence of cognitive impairment during recovery from COVID-19
From: Neurocognitive screening in patients following SARS-CoV-2 infection: tools for triage
|  | Impaired (< 9th percentile), n (%) | Odds ratio (95% CI) | ||
|---|---|---|---|---|
Total (N = 102) | Ambulatory (N = 76) | Hospitalized (N = 26) | Hospitalized vs Ambulatory | |
Neurocognitive Index | 9 (12%) | 6 (10%) | 3 (17%) | 1.18 (0.22–6.44) |
Verbal Memory | 20 (20%) | 12 (16%) | 8 (32%) | 2.39 (0.84–6.79) |
Visual Memory | 10 (10%) | 3 (4%) | 7 (30%) | 10.21 (2.38–43.85) |
Psychomotor Speed | 20 (11%) | 11 (15%) | 9 (41%) | 2.63 (0.82–8.40) |
Reaction Time | 10 (11%) | 6 (9%) | 4 (18%) | 2.22 (0.56–8.75) |
Complex Attention | 9 (11%) | 6 (10%) | 3 (15%) | 1.62 (0.37–7.12) |
Cognitive Flexibility | 16 (19%) | 11 (17%) | 5 (25%) | 1.58 (0.47–5.25) |